tiprankstipranks
Trending News
More News >
Tenet Healthcare (THC)
NYSE:THC
Advertisement

Tenet Healthcare (THC) AI Stock Analysis

Compare
921 Followers

Top Page

THC

Tenet Healthcare

(NYSE:THC)

Rating:75Outperform
Price Target:
$193.00
▼(-1.62% Downside)
Tenet Healthcare's strong earnings call and attractive valuation are the most significant factors driving the score. The company's financial performance shows stability but is pressured by high leverage and decreased profitability. Technical indicators suggest positive momentum, though caution is warranted due to potential overbought conditions. The strategic appointment of a new COO adds a positive outlook for operational leadership.
Positive Factors
Business Growth
Tenet Healthcare Corp. opened 8 new centers focused on high acuity, which positions the company well to benefit from changes in Medicare policies.
Earnings
The guidance was increased $395m at the midpoint which is higher than expected.
Shareholder Value
THC has bought back $1.1b of stock and announced another $1.5b authorization, combined 16% of the market cap.
Negative Factors
Exchange Market Volatility
Some volatility in the exchange marketplace is possible even with approval.
Legislative Risks
Investor angst likely increases operating bar due to legislative headwinds.
Subsidy Risks
A headwind of $265 million is expected in the acute segment due to potential subsidy losses in 2026.

Tenet Healthcare (THC) vs. SPDR S&P 500 ETF (SPY)

Tenet Healthcare Business Overview & Revenue Model

Company DescriptionTenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
How the Company Makes MoneyTenet Healthcare generates revenue primarily through the provision of healthcare services, which includes patient care services in its hospitals, surgical centers, and outpatient facilities. The company earns money from patient admissions, surgeries, diagnostic tests, and ancillary services, billed primarily through third-party payers such as Medicare, Medicaid, and private insurance companies. Key revenue streams include inpatient and outpatient services, which account for a significant portion of their earnings. Additionally, Tenet has partnerships with various healthcare organizations and payers that contribute to its revenue, as well as investments in value-based care initiatives that align reimbursement with patient outcomes. The company's ability to manage operational efficiency and cost structures also plays a crucial role in its overall profitability.

Tenet Healthcare Key Performance Indicators (KPIs)

Any
Any
Total Hospitals
Total Hospitals
Indicates the number of hospitals operated, reflecting the scale of operations and market presence. A larger network can drive higher revenue and provide competitive advantages in negotiating with insurers and suppliers.
Chart InsightsTenet Healthcare's total number of hospitals has decreased significantly since 2020, with a notable drop in 2024. Despite this reduction, the company has reported strong financial performance in early 2025, with robust revenue and EBITDA growth. The strategic focus on ambulatory space M&A and operational excellence is likely compensating for the reduced hospital count. However, uncertainties in healthcare policy, particularly around Medicaid, could pose challenges. The company's cautious approach to 2025 guidance reflects these uncertainties, despite a promising start to the fiscal year.
Data provided by:Main Street Data

Tenet Healthcare Earnings Call Summary

Earnings Call Date:Jul 22, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 16, 2025
Earnings Call Sentiment Positive
The earnings call was generally positive, highlighting strong financial performance and growth in key segments like USPI and hospitals. The company raised its full-year guidance, supported by robust fundamentals. However, challenges such as volume deceleration and increased denials and disputes were noted, but they were outweighed by the positive aspects.
Q2-2025 Updates
Positive Updates
Strong Financial Performance
Second quarter 2025 net operating revenues reached $5.3 billion with a consolidated adjusted EBITDA of $1.121 billion, marking a 19% increase over 2024. The adjusted EBITDA margin improved by 280 basis points to 21.3%.
USPI Growth
USPI generated $498 million in adjusted EBITDA, an 11% growth over the previous quarter. Same facility revenues grew by 7.7%, with a 12.6% increase in total joint replacements in ASCs.
Hospital Segment Performance
Hospital segment adjusted EBITDA grew 25% to $623 million with same-store hospital admissions up 1.6%. Revenue per adjusted admission increased by 5.2%.
Share Repurchase Program Expansion
Tenet Healthcare has deployed $1.1 billion to repurchase 7.2 million shares in the first half of 2025. The board authorized a $1.5 billion increase in the share repurchase program.
Raised Full-Year Guidance
The company raised its full-year 2025 adjusted EBITDA guidance to a range of $4.4 to $4.54 billion, an increase of $395 million or 10% at the midpoint.
Negative Updates
Volume Deceleration
There was a noted deceleration in both inpatient and adjusted admissions volumes, leading to a 50 basis point reduction in volume guidance.
Increased Denials and Disputes
The company reported an increase in denials and disputes post-COVID, describing some of the activities as not acceptable and requiring adaptation through technology.
Company Guidance
During the second quarter of 2025, Tenet Healthcare Corporation reported robust financial outcomes, with net operating revenues reaching $5.3 billion and consolidated adjusted EBITDA of $1.121 billion, marking a 19% increase over the previous year. The adjusted EBITDA margin improved by 280 basis points to 21.3%, supported by strong same-store growth and efficient operations. USPI contributed significantly, with a $498 million adjusted EBITDA, reflecting an 11% increase over the prior year. Same facility revenues rose by 7.7%, highlighted by a 12.6% growth in total joint replacements in ASCs. The hospital segment also saw a 25% growth in adjusted EBITDA to $623 million, with same-store hospital admissions increasing by 1.6% and revenue per adjusted admission rising by 5.2%. The organization enhanced its full-year 2025 adjusted EBITDA guidance to a range of $4.4 to $4.54 billion, indicating an approximate 10% increase from previous guidance. The company also reduced its overhead by downsizing its hospital portfolio and authorized a $1.5 billion increase in its share repurchase program, demonstrating a commitment to shareholder value through disciplined financial management and strategic capital allocation.

Tenet Healthcare Financial Statement Overview

Summary
Tenet Healthcare shows stable revenue and strong returns on equity, but profitability has decreased, and high leverage poses financial risk. Cash flow generation is robust, but improving margins and managing debt are crucial.
Income Statement
75
Positive
Tenet Healthcare shows a stable revenue stream with a slight increase from $20.65B to $20.69B TTM. Gross profit margins are healthy at approximately 47.81% for TTM. The net profit margin, however, has decreased to 7.17% from the previous annual figure of 15.49%, indicating a significant drop in profitability. EBIT and EBITDA margins have also decreased, reflecting operational challenges.
Balance Sheet
60
Neutral
The company maintains a high debt-to-equity ratio of 3.51 in TTM, which indicates a significant reliance on leverage. The equity ratio is low at around 13.06%, suggesting potential financial risk if not managed effectively. However, return on equity is strong at 39.59%, indicating effective utilization of equity to generate profits.
Cash Flow
70
Positive
Free cash flow has grown from $1.12B to $1.56B, an increase of 39.64%, highlighting improved cash generation. The operating cash flow to net income ratio of 1.66 indicates solid cash generation relative to accounting profits. However, the free cash flow to net income ratio of 1.05 shows slightly lower cash conversion efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue20.69B20.66B20.55B19.17B19.48B17.64B
Gross Profit10.60B8.21B7.80B7.05B7.27B6.23B
EBITDA4.62B6.89B3.39B3.08B3.67B2.53B
Net Income1.48B3.20B611.00M411.00M914.00M399.00M
Balance Sheet
Total Assets28.70B28.94B28.31B27.16B27.58B27.11B
Cash, Cash Equivalents and Short-Term Investments2.63B3.02B1.23B858.00M2.36B2.45B
Total Debt13.18B13.17B15.00B15.08B15.65B15.72B
Total Liabilities20.40B20.39B22.80B22.55B23.32B24.22B
Stockholders Equity3.75B4.17B1.61B1.14B1.03B28.00M
Cash Flow
Free Cash Flow1.56B1.12B1.62B321.00M910.00M2.87B
Operating Cash Flow2.46B2.05B2.37B1.08B1.57B3.41B
Investing Cash Flow-267.00M3.25B-969.00M-808.00M-714.00M-1.61B
Financing Cash Flow-2.45B-3.51B-1.03B-1.78B-936.00M385.00M

Tenet Healthcare Technical Analysis

Technical Analysis Sentiment
Positive
Last Price196.18
Price Trends
50DMA
171.80
Positive
100DMA
162.55
Positive
200DMA
147.96
Positive
Market Momentum
MACD
6.43
Negative
RSI
78.20
Negative
STOCH
96.58
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For THC, the sentiment is Positive. The current price of 196.18 is above the 20-day moving average (MA) of 178.96, above the 50-day MA of 171.80, and above the 200-day MA of 147.96, indicating a bullish trend. The MACD of 6.43 indicates Negative momentum. The RSI at 78.20 is Negative, neither overbought nor oversold. The STOCH value of 96.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for THC.

Tenet Healthcare Risk Analysis

Tenet Healthcare disclosed 25 risk factors in its most recent earnings report. Tenet Healthcare reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Tenet Healthcare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$12.10B10.0118.66%0.42%9.61%39.65%
75
Outperform
$17.33B12.5641.09%-1.09%-43.10%
73
Outperform
$12.65B24.5525.35%0.54%11.80%30.02%
71
Outperform
$14.43B20.184.72%3.18%1.11%25.84%
71
Outperform
$98.46B17.67-230.22%0.66%6.37%11.25%
62
Neutral
$9.86B13.55635.30%5.09%7.85%
51
Neutral
$7.95B-0.40-42.50%2.21%22.29%-1.85%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
THC
Tenet Healthcare
196.18
42.96
28.04%
DVA
DaVita
137.87
-12.37
-8.23%
FMS
Fresenius Medical Care
24.77
5.25
26.90%
HCA
HCA Healthcare
420.77
38.88
10.18%
EHC
Encompass Health
125.58
34.82
38.36%
UHS
Universal Health
190.12
-35.42
-15.70%

Tenet Healthcare Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Tenet Healthcare Appoints Lisa Y. Foo as COO
Positive
Jun 5, 2025

On May 30, 2025, Tenet Healthcare Corporation announced the promotion of Lisa Y. Foo to the newly created position of Chief Operating Officer, effective immediately. This strategic move is expected to enhance the company’s operational leadership and potentially strengthen its market position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025